Gossamer Bio is set to report the results of its Phase 3 clinical trial focused on pulmonary arterial hypertension (PAH), a progressive lung disease, by the...
Sanofi and its partner, Orano Med, announced on October 25, 2023, that their alpha-emitting radiopharmaceutical candidate has achieved a significant milestone in its Phase 2 clinical...
Cryptocurrency enthusiasts are turning their attention to Ruvi AI (RUVI), an innovative token that is gaining traction following its listing on CoinMarketCap (CMC). The project has...
